Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS)

Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS)

US Patent 8129360 · Granted Mar 6, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1-methylxanthine-based bioactive composition and method of use thereof2025
Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules2024
Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules2021
Method for increasing muscle mass and strength2020
Rice protein supplement and methods of use thereof2019
Rice protein supplement and methods of use thereof2017
Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof t2012
Physiologically-active composition based on collagen2010
Method for the production of phospholipids2006
Use of creatine and/or creatine derivatives for treating typical disorders in wo2003